View Single Post
 
Old Jul 11, 2025, 01:49 AM
Moose72's Avatar
Moose72 Moose72 is online now
Silver Swan
 
Member Since: Jan 2008
Location: USA
Posts: 18,487
The report describes the position of an intrauterine device (IUD) within the endometrial cavity. However, its full extent is not clearly visible due to a potential folding or embedding of its parts within the myometrial wall, which is the muscular layer of the uterus. This suggests a possibility of myometrial penetration. The visible portion of the endometrium, the inner lining of the uterus, measures 0.3 cm. The right and left ovaries were not identified in the examination.
In cases of IUD myometrial penetration, removal of the device is usually recommended. This is particularly true if the patient experiences symptoms such as pain or bleeding. The removal method will depend on the degree of embedment and may range from a simple office procedure to a hysteroscopic removal, which might be performed under anesthesia. In some cases, a laparoscopy or even a laparotomy (abdominal surgery) might be necessary, especially if there are complications or severe pelvic adhesions.
It is important to remember that IUDs can still be effective at preventing pregnancy even with some degree of malpositioning. However, the report mentions that the IUD is poorly delineated, which may suggest that its contraceptive effectiveness could be compromised. Therefore, until the situation is resolved, it's advisable to use alternative contraception.
In the context of the endometrial thickness, a measurement of 0.3 cm is within the typical range during the menstrual phase (days 1-5), where the endometrium is shedding. However, the normal range of endometrial thickness varies throughout the menstrual cycle. The presence of the IUD might limit a complete evaluation of the endometrium, according to Dr.Oracle.
If there are any concerns about the IUD's position or effectiveness, or if symptoms such as pain, unusual bleeding, or missing strings arise, it's essential to consult with a healthcare provider for further evaluation and guidance. According to the NHS, they can assess the situation and recommend the appropriate course of action, which could involve additional imaging tests like ultrasound or X-ray to better visualize the IUD's location.
__________________
Qui Cantat Bis Orat ingrezza 80 mg
Propranolol 40 mg Benztropine 1 mg
Vraylar 3 mg
Gabapentin 300 mg
Klonopin 1 mg 2x daily
Mania Sept/Oct 2024
Mania (July/August 2024)
Mania (December 2023)
Mixed episode/Hypomania (September 2023)
Depression, Anxiety and Intrusive thoughts (September 2021)
Depression & Psychosis (July/August 2021)